Norheim, K
10.1016/j.redox.2017.12.019 Summary Keywords liver fibrosis, thioacetamide, Nrf2, SIRT1, oxidative stress, remogliflozin Citation ALSuhaymi N, Alsugoor MH, Shokry AA, Fayed HM, Mohamed BMSA, Afifi SM, Esatbeyoglu T, Korany RMS and Elbaset MA (2025) Protective role of remogliflozin against experimental liver fibrosis by activating AMPK/SIRT1/Nrf2 and suppressing NF-B pathways
Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency
It really puts companies in a difficult spot. Dianne Munevar, head of Healthsperiens center for health, research, policy, and strategy, said that while telehealth companies offering prescription drugs would still fall under FDA jurisdiction, there are regulatory gray areas when these companies offer compounded medications that do not receive FDA approval. Munevar co-authored a study this year on ways to strengthen oversight of drug promotions on social media, suggesting the agency should clarify its regulatory authority under the Federal Food, Drug, and Cosmetic Act with respect to false and misleading advertising of compounded drugs